NCT05927246

Radiotherapy-Associated Atrial Fibrillation

Radiotherapy-associated Atrial Fibrillation: Onset Time and Frequency

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 400 (actual)
• Sponsor: Istanbul University · Academic / Other
• Sex: All
• Age: 18 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

Radiotherapy associated Atrial Fibrillation (RADAF) is an observational study to evaluate onset time and frequency of atrial fibrillation in patients with thoracic malignancies and breast cancer. Each patient will have 12 lead ECG prior, and daily during radiotherapy.

Detailed description

Collected data will be truly anonymised and individuals will no longer identifiable, and than evaluated for occurrence of atrial fibrillation. Inclusing Criteria: 1. Patients with radiotherapy for thoracic malignancy or breast cancer 2. Between 18-99 years-old Exclusion Criteria: 1. Patients with history of radiotherapy 2. Patients with history of atrial fibrillation 3. Patients with pacemaker implantation

Conditions

• Atrial Fibrillation New Onset

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	ECG	12 lead ecg for each participant

Timeline

• Start date: 2023-01-01
• Primary completion: 2023-06-01
• Completion: 2023-06-01
• First posted: 2023-07-03
• Last updated: 2023-07-03

Locations

1 site across 1 country: Turkey (Türkiye)